Equities

Tristel PLC

TSTL:LSE

Tristel PLC

Health CareHealth Care Providers
  • Price (GBX)462.50
  • Today's Change0.00 / 0.00%
  • Shares traded7.56k
  • 1 Year change40.15%
  • Beta0.3515
Data delayed at least 20 minutes, as of May 02 2024 14:49 BST.
More ▼

Financials data is unavailable for this security.

Inc stmt in GBPIncome statement in GBPView more

Year on year Tristel PLC grew revenues 15.70% from 31.12m to 36.01m while net income improved 351.98% from 987.00k to 4.46m.
Gross margin82.59%
Net profit margin15.29%
Operating margin15.64%
Return on assets15.17%
Return on equity20.11%
Return on investment17.10%
More ▼

Cash flow in GBPView more

In 2023, cash reserves at Tristel PLC fell by 1.77m. However, the company earned 8.49m from its operations for a Cash Flow Margin of 23.58%. In addition the company used 4.85m on investing activities and also paid 5.44m in financing cash flows.
Cash flow per share0.1781
Price/Cash flow per share25.69
Book value per share0.6567
Tangible book value per share0.4514
More ▼

Balance sheet in GBPView more

Tristel PLC has a Debt to Total Capital ratio of 16.05%, a lower figure than the previous year's 16.36%.
Current ratio4.92
Quick ratio3.93
Total debt/total equity0.1913
Total debt/total capital0.1605
More ▼

Growth rates in GBP

Year on year, both dividends per share and earnings per share excluding extraordinary items growth increased 60.31% and 355.95%, respectively. The positive trend in dividend payments is noteworthy since very few companies in the Medical Equipment & Supplies industry pay a dividend. Additionally when measured on a five year annualized basis, both dividend per share and earnings per share growth ranked above the industry average relative to its peers.
Div yield(5 year avg)1.84%
Div growth rate (5 year)18.05%
Payout ratio (TTM)102.92%
EPS growth(5 years)5.15
EPS (TTM) vs
TTM 1 year ago		74.26
More ▼
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.